相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Joydeb Majumder et al.
AAPS JOURNAL (2021)
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomes
Peter E. Penson et al.
ATHEROSCLEROSIS (2021)
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management
Abubakar Umar Anka et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
Dragana Nikolic et al.
DIABETES THERAPY (2021)
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study
Hiroaki Ikezaki et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Diversity of macrophage phenotypes and responses in atherosclerosis
Hiroyuki Jinnouchi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Inclisiran-New hope in the management of lipid disorders?
Krzysztof Dyrbus et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2020)
An overview of statin-induced myopathy and perspectives for the future
Dragana Nikolic et al.
EXPERT OPINION ON DRUG SAFETY (2020)
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
Angelo Maria Patti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP)
Arrigo F. G. Cicero et al.
NUTRITION RESEARCH REVIEWS (2020)
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
Maciej Banach et al.
JAMA CARDIOLOGY (2020)
LDL-C: lower is better for longer-even at low risk
Peter E. Penson et al.
BMC MEDICINE (2020)
An update on PCSK9 inhibitors- pharmacokinetics, drug interactions, and toxicity
Svetlana Mosteoru et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis
Arrigo F. G. Cicero et al.
PLOS MEDICINE (2020)
Inflammation of carotid plaques and risk of cerebrovascular events
Pavel Poredos et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Daily Use of Extra Virgin Olive Oil with High Oleocanthal Concentration Reduced Body Weight, Waist Circumference, Alanine Transaminase, Inflammatory Cytokines and Hepatic Steatosis in Subjects with the Metabolic Syndrome: A 2-Month Intervention Study
Angelo M. Patti et al.
METABOLITES (2020)
Statins and LDL-C in Secondary Prevention-So Much Progress, So Far to Go
Maciej Banach et al.
JAMA NETWORK OPEN (2020)
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Donna K. Arnett et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels - experimental and clinical approaches with lipid-lowering agents
C. Macchi et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)
The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway
Giorgio Aquila et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials
Federica Fogacci et al.
PHARMACOLOGICAL RESEARCH (2019)
Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial
Natia Peradze et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
Michael J. Koren et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials
Federica Fogacci et al.
PHYTOTHERAPY RESEARCH (2019)
Future perspectives of the pharmacological management of diabetic dyslipidemia
Angelo Maria Patti et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
Renato Quispe et al.
ARCHIVES OF MEDICAL SCIENCE (2019)
Management of Statin Intolerance in 2018: Still More Questions Than Answers
Peter P. Toth et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2018)
Natural approaches in metabolic syndrome management
Angelo Maria Patti et al.
ARCHIVES OF MEDICAL SCIENCE (2018)
High levels of lipoprotein (a) and premature acute coronary syndrome
Loukianos S. Rallidis et al.
ATHEROSCLEROSIS (2018)
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms
Manfredi Rizzo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Inhibition of nuclear translocation of notch intracellular domain (NICD) by diosgenin prevented atherosclerotic disease progression
Ambika Binesh et al.
BIOCHIMIE (2018)
Polyphenols: Inflammation
Midori Natsume
CURRENT PHARMACEUTICAL DESIGN (2018)
Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Kamal Awad et al.
DRUGS (2018)
Plaque Calcification During Atherosclerosis Progression and Regression
Atsushi Shioi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
The Role of Nutraceuticals in Statin Intolerant Patients
Maciej Banach et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Polydatin Protects Diabetic Heart against Ischemia-Reperfusion Injury via Notch1/Hes1-Mediated Activation of Pten/Akt Signaling
Liming Yu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Stimulation of the endogenous incretin glucose-dependent insulinotropic peptide by enteral dextrose improves glucose homeostasis and inflammation in murine endotoxemia
Faraaz Ali Shah et al.
TRANSLATIONAL RESEARCH (2018)
The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE-/- mice by blocking monocyte/macrophage activation
Florian Kahles et al.
MOLECULAR METABOLISM (2018)
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
Marnix Lameijer et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Glucose-Dependent Insulinotropic Polypeptide Suppresses Peripheral Arterial Remodeling in Male Mice
Yusaku Mori et al.
ENDOCRINOLOGY (2018)
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways
Gunaj Rakipovski et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity
Julie B. Hjerpsted et al.
DIABETES OBESITY & METABOLISM (2018)
Lipoprotein(a) Levels in Patients With Abdominal Aortic Aneurysm: A Systematic Review and Meta-Analysis
Kazuhiko Kotani et al.
ANGIOLOGY (2017)
ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy
Michele Massimo Gulizia et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2017)
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Robert P. Giugliano et al.
LANCET (2017)
A non-canonical Notch complex regulates adherens junctions and vascular barrier function
William J. Polacheck et al.
NATURE (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Kausik K. Ray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F. G. Cicero et al.
NUTRITION REVIEWS (2017)
Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response
Dong-Mee Lim et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Nutraceuticals as an Important Part of Combination Therapy in Dyslipidaemia
Angelo M. Patti et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity
S. N. Pokrovsky et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
The Effects of Tamoxifen on Plasma Lipoprotein(a) Concentrations: Systematic Review and Meta-Analysis
Amirhossein Sahebkar et al.
DRUGS (2017)
Small, dense LDL: an update
Philipp A. Gerber et al.
CURRENT OPINION IN CARDIOLOGY (2017)
2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside protects murine hearts against ischemia/reperfusion injury by activating Notch1/Hes1 signaling and attenuating endoplasmic reticulum stress
Meng Zhang et al.
ACTA PHARMACOLOGICA SINICA (2017)
Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB
Lisa M. Berglund et al.
DIABETES (2016)
EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway
Jianguo Yin et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis
Jie Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?
Yajnavalka Banerjee et al.
ATHEROSCLEROSIS (2016)
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
Manfredi Rizzo et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
Anti-cytokine therapy for prevention of atherosclerosis
Tatiana V. Kirichenko et al.
PHYTOMEDICINE (2016)
Anti-inflammatory role of glucose-dependent insulinotropic polypeptide in periodontitis
Yuki Suzuki et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
Peter P. Toth et al.
FRONTIERS IN PHARMACOLOGY (2016)
Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics
Kristian Karstoft et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling
Liming Yu et al.
APOPTOSIS (2015)
GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial
Oezlem Goegebakan et al.
DIABETOLOGIA (2015)
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Patrick M. Moriarty et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis
Anais Briot et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Effects of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-analysis of Randomized Controlled Trials
Maciej Banach et al.
MAYO CLINIC PROCEEDINGS (2015)
Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis
Enrico Ammirati et al.
MEDIATORS OF INFLAMMATION (2015)
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Jennifer G. Robinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Statin therapy and plasma coenzyme Q10 concentrations-A systematic review and meta-analysis of placebo-controlled trials
Maciej Banach et al.
PHARMACOLOGICAL RESEARCH (2015)
Nutraceuticals in Lipid-Lowering Treatment: A Narrative Review on the Role of Chitosan
Angelo Maria Patti et al.
ANGIOLOGY (2015)
Telomere shortening over 6 years is associated with increased subclinical carotid vascular damage and worse cardiovascular prognosis in the general population
A. Baragetti et al.
JOURNAL OF INTERNAL MEDICINE (2015)
ETC-1002: A future option for lipid disorders?
Dragana Nikolic et al.
ATHEROSCLEROSIS (2014)
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality
Marcin Barylski et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
S. Oravec et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Treatment options for managing atherogenic dyslipidemia and fatty liver disease
Manfredi Rizzo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Long-Acting Glucose-Dependent Insulinotropic Polypeptide Ameliorates Obesity-Induced Adipose Tissue Inflammation
Chen Varol et al.
JOURNAL OF IMMUNOLOGY (2014)
LDL cholesterol: controversies and future therapeutic directions
Paul M. Ridker
LANCET (2014)
Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
Akihiro Shindo et al.
PLOS ONE (2014)
Inflammatory markers in patients with internal carotid artery stenosis
Przemyslaw Puz et al.
ARCHIVES OF MEDICAL SCIENCE (2013)
Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis
Sanne Willems et al.
ATHEROSCLEROSIS (2013)
Flow cytometry and gene expression profiling of immune cells of the carotid plaque and peripheral blood
Zohara Sternberg et al.
ATHEROSCLEROSIS (2013)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
PCSK9 Inhibition - A Novel Mechanism to Treat Lipid Disorders?
Maciej Banach et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial
Anastazia Kei et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Non-glycemic effects of pioglitazone and incretin-based therapies
Manfredi Rizzo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy
Peter Libby
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Role of Glucose-Dependent Insulinotropic Polypeptide in Adipose Tissue Inflammation of Dipeptidylpeptidase 4-Deficient Rats
Shani Ben-Shlomo et al.
OBESITY (2013)
Norisoboldine Suppresses VEGF-Induced Endothelial Cell Migration via the cAMP-PKA-NF-κB/Notch1 Pathway
Qian Lu et al.
PLOS ONE (2013)
Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes
Burton M. Wice et al.
DIABETES (2012)
Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease
Yuji Takahashi et al.
HEART AND VESSELS (2012)
Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties
A. Ojima et al.
HORMONE AND METABOLIC RESEARCH (2012)
Rosiglitazone Ameliorates Diabetic Nephropathy by Reducing the Expression of Chemerin and ChemR23 in the Kidney of Streptozotocin-Induced Diabetic Rats
Wenchao Hu et al.
INFLAMMATION (2012)
Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice
Michishige Terasaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Notch ligand endocytosis: Mechanistic basis of signaling activity
Abdiwahab A. Musse et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Oxidative stress and small, dense low-density lipoproteins: current and future perspectives
Ali A. Rizvi et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2012)
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Dimitri P. Mikhailidis et al.
Current Vascular Pharmacology (2011)
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
M. Nagashima et al.
DIABETOLOGIA (2011)
High Versus Standard Clopidogrel Maintenance Dose After Percutaneous Coronary Intervention and Effects on Platelet Inhibition, Endothelial Function, and Inflammation Results of the ARMYDA-150 mg (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) Randomized Study
Giuseppe Patti et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Inflammation dysregulates Notch signaling in endothelial cells: Implication of Notch2 and Notch4 to endothelial dysfunction
Thibaut Quillard et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Evidence for the Importance of Adiponectin in the Cardioprotective Effects of Pioglitazone
Ping Li et al.
HYPERTENSION (2010)
An Update on the Role of Markers of Inflammation in Atherosclerosis
Egle Corrado et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
Ethnic differences in serum lipoproteins and their determinants in South African women
Julia H. Goedecke et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Shear Stress Increases Expression of the Arterial Endothelial Marker EphrinB2 in Murine ES Cells via the VEGF-Notch Signaling Pathways
Tomomi Masumura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
The effects of ezetimibe on LDL-cholesterol: Quantitative or qualitative changes?
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2009)
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2009)
Multiple Biological Predictors for Vulnerable Carotid Lesions
Jaroslav Pelisek et al.
CEREBROVASCULAR DISEASES (2009)
Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
Manfredi Rizzo et al.
CLINICAL ENDOCRINOLOGY (2009)
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Thea Morris et al.
JOURNAL OF IMMUNOLOGY (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on notch regulation of MMP-2/-9
Sandrine Delbosc et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes
Helmut Laumen et al.
ATHEROSCLEROSIS (2008)
Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2008)
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2008)
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study
Egle Corrado et al.
CORONARY ARTERY DISEASE (2008)
Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes
M. Rizzo et al.
DIABETIC MEDICINE (2008)
The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?
Manfredi Rizzo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes
Kaspar Berneis et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Effect of simavastatin on IL-6 and adiponectin secretion and mRNA expression in 3T3-L1 adipocytes
Yin Xiaoming et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2007)
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression
Fernando O. Martinez et al.
JOURNAL OF IMMUNOLOGY (2006)
Sp1 mediates repression of the resistin gene by PPARγ agonists in 3T3-L1 adipocytes
S. S. Chung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis
Carmine Cardillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Glucose-dependent insulinotropic peptide: differential effects on hepatic artery vs. portal vein endothelial cells
KH Ding et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
K Miyawaki et al.
NATURE MEDICINE (2002)
Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma -: A novel collagenolytic pathway suggested by transcriptional profiling
MP Herman et al.
CIRCULATION (2001)
分享论文
